Almac Pharma Services has successfully completed its first U.S. FDA inspection of its commercial manufacturing facility in Charnwood, England. The pre-approval inspection was related to a solid oral dose product which the site will manufacture for a global pharmaceutical company. On completion, the inspector concluded the facility, systems and practices comply with FDA requirements with no Form 483 observations or comments reported. Almac Pharma Services’ facility, which is set within th...